Constitutive retinoid receptors expressed from adenovirus vectors that specifically activate chromosomal target genes required for differentiation of promyelocytic leukemia and teratocarcinoma cells

Journal of Virology

Volumn 70, Issue 10, 1996, Pages 7182-7189

  Lipkin, Steven M ^a   Grider, Teresa L ^a   Heyman, Richard A ^b   Glass, Christopher K ^c   Gage, Fred H ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b LIGAND PHARMACEUTICALS INC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID RECEPTOR;

ADENOVIRUS; ARTICLE; CELL DIFFERENTIATION; EXPRESSION VECTOR; GENE EXPRESSION REGULATION; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; REPORTER GENE; SIGNAL TRANSDUCTION; TERATOCARCINOMA; TRANSACTIVATION; TUMOR SUPPRESSOR GENE; VIRUS EXPRESSION;

EID: 0029792294     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.10.7182-7189.1996     Document Type: Article

References (33)

1. Breitman, T., S. E. Selonick, and S. Collins. 1980. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA 77:2936-2940.
2. Chanock, S., J. el Benna, R. Smith, and B. Barbior. 1994. The respiratory hurst oxidase. J. Biol. Chem. 269:24519-24522.
3. Chen, P. L., Y. M. Chen, R. Bookstein, and W. H. Lee. 1990. Genetic mechanisms of tumor suppression by the human p53 gene. Science 247:712-715.
4. Choo, Y., I. Sanchez-Garcia, and A. Klug. 1994. In vivo repression by a site-specific DNA-binding protein designed against an oncogenic sequence. Nature (London) 372:642-645.
5. Clayman, G., A. el-Naggar, J. Roth, W. Zhang, H. Goepfert, D. Taylor, and J. Liu. 1995. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res. 55:1-6.
6. Denecke, B., S. Bartkowski, S. Senkel, L. Klein-Hitpass, and G. U. Ryffel. 1993. Chimeric liver transcription factors LFB1 (HNF1) containing the acidic activation domain of VP16 act as positive dominant interfering mutants. J. Biol. Chem. 268:18076-18082.
7. de The, H., C. Chomienne, M. Lanotte, L. Degos, and A. Dejean. 1990. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature (London) 347:558-561.
8. Forman, B. M., K. Umesono, J. Chen, and R. M. Evans. 1995. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81:541-550.
9. Gilbert, D. M., D. M. Heery, R. Losson, P. Chambon, and Y. Lemoine. 1993. Estradiol-inducible Saccharomyces cerevisiae: suppression by an allele of PDR1. Mol. Cell. Biol. 13:462-472.
10. Gill, G., and M. Ptashne. 1988. Negative effect of the transcriptional activator GAL4. Nature (London) 334:721-724.
11. Glass, C. K. 1994. Differential recognition of target genes by nuclear receptor monomers, dimers and heterodimers. Endocr. Rev. 15:1503-1519.
12. Hoffmann, B., J. M. Lehmann, X. K. Zhang, T. Hermann, M. Husmann, G. Graupner, and M. Pfahl. 1990. A retinoic acid receptor-specific element controls the retinoic acid receptor-beta promoter. Mol. Endocrinol. 4:1727-1736.
13. Hörlein, A., A. Näär, T. Heinzel, J. Torchia, B. Gloss, R. Kurokawa, Y. Kamai, A. Ryan, M. Söderström, C. K. Glass, and M. G. Rosenfeld. 1995. Ligand-independent repression by the thyroid hormone receptor is mediated by a nuclear receptor co-repressor, N-CoR. Nature (London) 377:397-404.
14. Kim, T. K., S. Hashimoto, R. J. Kelleher, P. M. Flanagan, R. D. Kornberg, M. Horikoshi, and R. G. Roeder. 1994. Effects of activation-defective TBP mutations on transcription initiation in yeast. Nature (London) 369:252-255.
15. Kurokawa, R., J. DiRenzo, M. Boehm, J. Sugarman, B. Gloss, M. G. Rosenfeld, R. A. Heyman, and C. K. Glass. 1994. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature (London) 371:528-531.
16. Kurokawa, R., M. Söderström, A. Hörlein, S. Halachmi, M. Brown, M. G. Rosenfeld, and C. K. Glass. 1995. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature (London) 377:451-454.
17. Lee, J. W., F. Ryan, J. C. Swaffield, S. A. Johnston, and D. D. Moore. 1995. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature (London) 374:91-94.
18. Lefstin, J. A., J. R. Thomas, and K. R. Yamamoto. 1994. Influence of a steroid receptor DNA-binding domain on transcriptional regulatory functions. Genes Dev. 8:2842-2856.
19. Lipkin, S. M., C. A. Nelson, C. K. Glass, and M. G. Rosenfeld. 1992. A negative retinoic acid response element in the rat oxytocin promoter restricts transcriptional stimulation by heterologous transactivation domains. Proc. Natl. Acad. Sci. USA 89:1209-1213.
20. Mangelsdorf, D. J., K. Umesono, S. A. Kliewer, U. Borgmeyer, E. S. Ong, and R. M. Evans. 1991. A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR. Cell 66:555-561.
21. Nagy, L., V. Thomazy, G. Shipley, L. Fesus, W. Lamph, R. A. Heyman, R. A. S. Chandraratna, and P. J. A. Davies. 1995. Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol. Cell. Biol. 15:3540-3551.
22. Pleasure, S., and V. Lee. 1993. NTera 2 cells: a human cell line which displays characteristics expected of a human committed neuronal progenitor cell. J. Neurosci. Res. 35:585-602.
23. Pomerantz, J., P. Sharp, and C. Pabo. 1995. Structure-based design of transcription factors. Science 267:93-96.
24. Sadovsky, Y., P. Webb, G. Lopez, J. D. Baxter, P. M. Fitzpatrick, E. Gizang-Ginsberg, V. Cavailles, M. G. Parker, and P. J. Kushner. 1995. Transcriptional activators differ in their responses to overexpression of TATA box-binding protein. Mol. Cell. Biol. 15:1554-1563.
25. Schuur, E. R., E. J. Parker, and P. Vogt, 1993. Chimeras of herpes simplex viral VP16 and jun are oncogenic. Cell Growth Differ. 4:761-768.
26. Silverman, N., J. Agapite, and L. Guanrente. 1994. Yeast ADA2 protein binds to the VP16 protein activation domain and activates transcription. Proc. Natl. Acad. Sci. USA 91:11665-11668.
27. Smarda, J., J. Sugarman, C. K. Glass, and J. Lipsick. 1995. Retinoic acid receptor alpha suppresses transformation by v-myb. Mol. Cell. Biol. 15:2474-2481.
28. Sucov, H. M., K. K. Murakami, and R. M. Evans. 1990. Characterization of an autoregulated response element in the mouse retinoic acid receptor type beta gene. Proc. Natl. Acad. Sci. USA 87:5392-5396.
29. Tsai, S., S. Bartelmez, R. Heyman, K. Damm, R. Evans, and S. J. Collins. 1992. A mutated retinoic acid receptor-alpha exhibiting dominant-negative activity alters the lineage development of a multipotent hematopoietic cell line. Genes Dev. 6:2258-2269.
30. Wills, K., D. Maneval, P. Menzel, M. Harris, S. Sutjipto, M. Vaillancourt, W. Huang, D. Johnson, S. Anderson, and S. Wen. 1994. Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer. Hum. Gene Ther. 5:1079-1088.
31. Xiao, H., A. Pearson, B. Coulombe, R. Truant, S. Zhang, J. L. Regier, S. J. Triezenberg, D. Reinberg, O. Flores, and C. J. Ingles. 1993. Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. J. Biol. Chem. 268:18076-18082.
32. Yankulov, K., J. Blau, T. Purton, S. Roberts, and D. L. Bentley. 1994. Transcriptional elongation by RNA polymerase II is stimulated by transactivators. Cell 77:749-759.
33. Yokomori, K., M. P. Zeidler, J. L. Chen, C. P. Verrijzer, M. Mlodzik, R. Tjian, A. Pearson, B. Coulombe, R. Truant, and S. Zhang. 1994. Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Mol. Cell. Biol. 14:7013-7024.